News
On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
New publication - VIV Team in Nature communication
Several CIRI teams carried out this work, published in the journal Science Translational Medicine.
The protein that opens doors to the medicine of the future and treatment of COVID-19
Retrouvez son portrait ici
Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.
Maladies infectieuses émergentes
The Club Francophone des Cellules Dendritiques (CFCD) is organizing its annual congress in Paris from October 16 to 17, 2021 on “DC-phering mononuclear phagocyte biology in health and disease". Program and information for registration on http://www.cfcd.fr/meeting/registration.php
— Institut Necker Enfants Malades (INEM), ParisModulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.
Félicitations à F Ader et B Horvat
A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates. Nature Microbiology, Jan 2023